TrialFrontiers in immunology2022

A randomized clinical trial to stimulate the cholinergic anti-inflammatory pathway in patients with moderate COVID-19-pneumonia using a slow-paced breathing technique.

Elisabeth Maria Balint et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.